96300-88-8

Basic information

• Product Name: 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE
• Synonyms: 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE;2-Pyridinemethanol, 4-methoxy-3,5-dimethyl-, hydrochloride;(4-Methoxy-3,5-diMethylpyridin-2-yl)Methanol Hydrochloride
• CAS NO: 96300-88-8
• Molecular Formula: C₉H₁₃NO₂*ClH
• Molecular Weight: 0
• Product Categories: API intermediates
• Mol File: 96300-88-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly)
• Stability: Hygroscopic
• CAS DataBase Reference: 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE(96300-88-8)
• EPA Substance Registry System: 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE(96300-88-8)

Safety Data

• Hazardous Substances Data: 96300-88-8(Hazardous Substances Data)

Usage

Description

3,5-DIMETHYL-4-METHOXY-2-PYRIDINE, also known as (4-Methoxy-3,5-dimethylpyridin-2-yl)methanol, is an organic compound with the chemical formula C8H11NO2. It is a derivative of pyridine, featuring two methyl groups at the 3rd and 5th positions, and a methoxy group at the 4th position. 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE is a key intermediate in the synthesis of various pharmaceuticals and has potential applications in the chemical and pharmaceutical industries.

Uses

Used in Pharmaceutical Industry:
3,5-DIMETHYL-4-METHOXY-2-PYRIDINE is used as an intermediate in the synthesis of omeprazole, a widely prescribed medication for the treatment of acid-related disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers. Omeprazole is a proton pump inhibitor that reduces the production of stomach acid, providing relief from heartburn and promoting healing of the esophageal lining.
Additionally, 3,5-DIMETHYL-4-METHOXY-2-PYRIDINE may have potential applications in the development of other pharmaceuticals, given its unique chemical structure and reactivity. Its ability to form various derivatives and complexes with other molecules makes it a valuable building block in the synthesis of new drugs and therapeutic agents.

Upstream product

• 91219-90-8 (4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl acetate 
• 86604-80-0 4-methoxy-2,3,5-trimethylpyridine 1-oxide 
• 109371-20-2 4-chloro-2,3,5-trimethylpyridine 1-oxide 

Downstream Products

• 86604-75-3 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine hydrochloride 

Relevant articles and documents

Diversified synthesis of novel quinoline and dibenzo thiazepine derivatives using known active intermediates

The novel drug development to control resisting infections in conventional drug therapy is a need of today. Few antiulcer relative derivatives developed by approaching convergent synthesis. The derivatives synthesized successfully are dibenzo thiazepine-pyridine (SLN11-SLN15) and benzimidazole-hydroquinoline based derivatives (SLN16-SLN20). It involved the coupling through microwave, sonication and conventional techniques at final step. The efficient technology identified as sonication technique basically time and yield. The reported compounds were structural characterized by elemental analysis and spectral studies such as 1H, 13C NMR and MS.

[1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles

Tricyclic ethers of the general formula I STR1 wherein R represents a bond and R1 represents a 1-2C-alkylene radical which is completely or partly substituted by fluorine, or a chlorotrifluoroethylene radical, or R and R1 each represent a difluoromethylene radical, R2 represents hydrogen or a 1-3C-alkyl radical, R3 represents hydrogen or a 1-3C-alkyl or 1-3C-alkoxy radical, R4 represents hydrogen or a 1-3C-alkyl radical and n represents the number 0 or 1, and their salts are new compounds with a marked protective effect on the stomach.